T2	Disorder 36 51	cystic fibrosis
N1 	Reference T2 UMLS:C0010674	cystic fibrosis
T9	Disorder 209 224	cystic fibrosis
N2 	Reference T9 UMLS:C0010674	cystic fibrosis
T10	Pharmacological_substance 304 313	ivacaftor
N1000 	Reference T10 MeSH:C545203	ivacaftor
T11	Pharmacological_substance 315 321	VX-770
N1001 	Reference T11 MeSH:C545203	VX-770
T12	Disorder 386 401	cystic fibrosis
N3 	Reference T12 UMLS:C0010674	cystic fibrosis
T15	Pharmacological_substance 493 502	ivacaftor
N1002 	Reference T15 MeSH:C545203	ivacaftor
T18	Pharmacological_substance 1110 1119	ivacaftor
N1003 	Reference T18 MeSH:C545203	ivacaftor
T21	Disorder 1407 1422	Cystic Fibrosis
N4 	Reference T21 UMLS:C0010674	Cystic Fibrosis
T23	Pharmacological_substance 1614 1623	ivacaftor
N1004 	Reference T23 MeSH:C545203	ivacaftor
T27	Pharmacological_substance 1828 1837	ivacaftor
N1005 	Reference T27 MeSH:C545203	ivacaftor
T29	Pharmacological_substance 1948 1957	ivacaftor
N1006 	Reference T29 MeSH:C545203	ivacaftor
T30	Pharmacological_substance 2026 2035	ivacaftor
N1007 	Reference T30 MeSH:C545203	ivacaftor
T32	Pharmacological_substance 2069 2078	Ivacaftor
N1008 	Reference T32 MeSH:C545203	Ivacaftor
T4	Subject 22 30	patients
T6	Pharmacological_substance 267 274	placebo
N1009 	Reference T6 MeSH:D010919	placebo
T14	Subject 347 380	subjects 12 years of age or older
T16	Pharmacological_substance 946 953	placebo
N1010 	Reference T16 MeSH:D010919	placebo
T19	Pharmacological_substance 1203 1210	placebo
N1011 	Reference T19 MeSH:D010919	placebo
T7	Pharmacological_substance 2 18	CFTR potentiator
T25	Subject 440 448	Subjects
T31	Pharmacological_substance 574 581	placebo
N1012 	Reference T31 MeSH:D010919	placebo
T33	Subject 519 530	84 subjects
T34	Subject 583 585	83
T35	Pharmacological_substance 918 927	ivacaftor
N1013 	Reference T35 MeSH:C545203	ivacaftor
T37	Subject 1091 1099	Subjects
T39	Disorder 1151 1173	pulmonary exacerbation
T42	Pharmacological_substance 1695 1702	placebo
N1014 	Reference T42 MeSH:D010919	placebo
T44	Pharmacological_substance 1962 1969	placebo
N1015 	Reference T44 MeSH:D010919	placebo
T45	Pharmacological_substance 2046 2053	placebo
N1016 	Reference T45 MeSH:D010919	placebo
T47	Disorder 2237 2260	pulmonary exacerbations
